FDA Orange Book

Generic for Nexavar

Nexavar contains sorafenib. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Nexavar is sorafenib. 5 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

Run it in Rivvi

Map Nexavar and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Nexavar products in the Orange Book

Nexavar products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
tablet, oralEQ 200MG BASEMarketed (Rx)AB5AB

NDA 021923, held by BAYER HEALTHCARE PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic sorafenib

Approved generic versions of Nexavar
CompanyANDATE codeApprovedStrengths
MYLAN PHARMACEUTICALS INC207012AB (A-rated, therapeutically equivalent)September 10, 2020EQ 200MG BASE
TEVA PHARMACEUTICALS USA INC209567AB (A-rated, therapeutically equivalent)November 12, 2020EQ 200MG BASE
DR REDDYS LABORATORIES LTD216073AB (A-rated, therapeutically equivalent)June 7, 2022EQ 200MG BASE
YABAO PHARMACEUTICAL CO LTD BEIJING209050AB (A-rated, therapeutically equivalent)November 9, 2022EQ 200MG BASE
TORRENT PHARMACEUTICALS LTD217095AB (A-rated, therapeutically equivalent)April 12, 2023EQ 200MG BASE

Nexavar patents

Patents listed for Nexavar
PatentExpiresCoversUse codeNDA
8877933December 24, 2027Drug substance, Drug productU-1624021923
9737488September 10, 2028Drug productU-2107021923
9737488September 10, 2028Drug productU-1480021923
9737488September 10, 2028Drug productU-1696021923

Nexavar NDC codes

Questions

Is there a generic for Nexavar?

Yes. The generic name for Nexavar is sorafenib. 5 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

What is the generic name for Nexavar?

The active ingredient in Nexavar is sorafenib, per the FDA Orange Book.

When does the Nexavar patent expire?

The last patent listed for Nexavar in the Orange Book expires September 10, 2028. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Nexavar and Sorafenib

Try it on your own data today.

Free to start. Most teams are using it the same day.